A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

NCT06569056 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

578

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)

Interventions

DRUG: HRS-8427
DRUG: Imipenem and Cilastatin Sodium
DRUG: HRS-8427 placebo
DRUG: Imipenem and Cilastatin Sodium placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.